CYTK Earnings Cytokinetics Inc
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–39 of 39
| Q2 2026 | 2026-06-30 | -1.50 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | -1.67 | 2026-05-05 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -1.51 | 2026-02-26 | 10-K |
| FY 2025 | 2025-12-31 | -6.54 | 2026-02-26 | 10-K |
| Q3 2025 | 2025-09-30 | -2.55 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.12 | 2025-08-07 | 10-Q |
| Q1 2025 | 2025-03-31 | -1.36 | 2025-05-06 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -1.26 | 2025-02-27 | 10-K |
| FY 2024 | 2024-12-31 | -5.26 | 2025-02-27 | 10-K |
| Q3 2024 | 2024-09-30 | -1.36 | 2024-11-07 | 10-Q |
| Q2 2024 | 2024-06-30 | -1.31 | 2024-08-09 | 10-Q |
| Q1 2024 | 2024-03-31 | -1.33 | 2024-05-10 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -1.38 | 2024-02-28 | 10-K |
| FY 2023 | 2023-12-31 | -5.45 | 2024-02-28 | 10-K |
| Q3 2023 | 2023-09-30 | -1.35 | 2023-11-03 | 10-Q |
| Q2 2023 | 2023-06-30 | -1.34 | 2023-08-03 | 10-Q |
| Q1 2023 | 2023-03-31 | -1.38 | 2023-05-05 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -1.53 | 2023-03-01 | 10-K |
| FY 2022 | 2022-12-31 | -4.33 | 2023-03-01 | 10-K |
| Q3 2022 | 2022-09-30 | -1.52 | 2022-11-04 | 10-Q |
| Q2 2022 | 2022-06-30 | -0.23 | 2022-08-05 | 10-Q |
| Q1 2022 | 2022-03-31 | -1.05 | — | — |
| FY 2021 | 2021-12-31 | -2.80 | — | — |
| Q3 2021 | 2021-09-30 | -0.95 | — | — |
| Q2 2021 | 2021-06-30 | -0.86 | — | — |
| FY 2020 | 2020-12-31 | -1.97 | — | — |
| FY 2017 | 2017-12-31 | -2.59 | 2018-03-05 | 10-K |
| Q3 2017 | 2017-09-30 | -0.60 | 2017-11-03 | 10-Q |
| Q4 2016 | 2016-12-31 | 0.16 | 2017-03-06 | 10-K |
| FY 2016 | 2016-12-31 | 0.39 | 2017-03-06 | 10-K |
| Q3 2016 | 2016-09-30 | 0.77 | 2016-11-03 | 10-Q |
| Q2 2016 | 2016-06-30 | -0.29 | — | — |
| Q1 2016 | 2016-03-31 | -0.31 | — | — |
| FY 2015 | 2015-12-31 | -0.97 | — | — |
| Q3 2015 | 2015-09-30 | -0.23 | — | — |
| FY 2014 | 2014-12-31 | -0.41 | — | — |
| FY 2011 | 2011-12-31 | -0.72 | 2012-03-13 | 10-K |
| FY 2010 | 2010-12-31 | -0.77 | — | — |
| FY 2009 | 2009-12-31 | 0.42 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.